Abiopharma

Teva Pharmaceutical Industries Ltd. - Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

DuPont Announces Regular Quarterly Dividend on Common Stock

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET

Kymera Therapeutics Announces Proposed Public Offering

Glaukos - Glaukos Announces EU MDR Certification for iStentinfinite® and Other Leading MIGS Therapies

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies

H.B. Fuller Reports Second Quarter 2025 Results